ECHA and the Member States evaluate the information submitted by companies to examine the quality of the registration dossiers and the testing proposals and to clarify if a given substance constitutes a risk to human health or the environment.
Evaluation under REACH focuses on three different areas:
- Examination of testing proposals submitted by registrants
- Compliance check of the dossiers submitted by registrants
- Substance evaluation
Once the evaluation is done, registrants may be required to submit further information on the substance.
In line with Article 54 of the REACH Regulation, by 28 February of each year, ECHA has to publish a report on the progress it has made over the previous calendar year on its obligations in relation to evaluation. ECHA is specifically required to include recommendations to potential registrants to foster improvement in the quality of future registrations, in these reports.
Summary of Evaluation Report 2011 [PDF]
- Practical guide 1. How to report in vitro data[PDF] [EN]
- Practical guide 2. How to report weight of evidence[PDF] [EN]
- Practical guide 3. How to report robust study summaries[PDF] [EN]
- Practical guide 4. How to report data waiving[PDF] [EN]
- Practical guide 5. How to report (Q)SARs[PDF] [EN]
- Practical guide 6. How to report read-across and categories[PDF] [EN]
- Practical guide 10. How to avoid unnecessary testing on animals[PDF] [EN]
- Practical guide 12: How to communicate with ECHA in dossier evaluation[PDF] [EN]
- Practical Guide 14: How to prepare toxicological summaries in IUCLID and how to derive DNELs [PDF] [EN]
- Practical Guide 15: How to undertake a qualitative human health assessment and document it in a chemical safety report [PDF] [EN]